The Role of Review and Synthesis Methods in Decision Models

Evidence-Based Decisions and Economics: Health Care, Social Welfare, Education and Criminal Justice, Second Edition

Volumn , Issue , 2010, Pages 8-22

  Marsh, Kevin ^a  

^a Matrix Knowledge Group   (United Kingdom)

Author keywords

Analytic perspective costs and effects; Decision model as analytic tool; Decision models methodological developments; Decision models are frequently used to conduct economic evaluations; Economic evaluation is concerned with opportunity cost; Identifying and analysing evidence; Role of review and synthesis methods in decision models; Search strategies estimate decision model parameters; Systematic reviews of evidence beneficial and adverse effects of interventions; Using systematic reviews in economic evaluation

Indexed keywords

EID: 84881666875     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444320398.ch2     Document Type: Chapter

References (82)

1. Soto J. Health economic evaluations using decision analytic modelling. Principles and practices-utilization of a checklist to their development and appraisal. International Journal of Technology Assessment in Health Care 2002; 18(1): 94-111.
2. Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press, 2006.
3. Buxton MJ, Drummond MF, van Hout BA, et al. Modelling in economic evaluation: an unavoidable fact of life. Health Economics 1997; 6(3): 217-227.
4. Donaldson C, Mugford M, Vale L. Using systematic reviews in economic evaluation: the basic principles. In: Donaldson C, Mugford M, Vale L (eds) Evidence-Based Health Economics: from effectiveness to efficiency in systematic review. London: BMJ Books, 2002.
5. Lavis JN, Posada FB, Haines A, Osei E. Use of research to inform public policymaking. Lancet 2004; 364(Oct 30): 1615-1621.
6. Petticrew M, Roberts H. Systematic reviews-do they 'work'in informing decision-making around health inequalities? Health Economics Policy and Law 2008; 3(2): 197-211.
7. Welsh BC, Farrington DP (eds). Preventing Crime: What works for children, offenders, victims and places. Dordrecht: Springer Netherlands, 2005.
8. Gilbody SM, Petticrew M. Rational decision-making in mental health: the role of systematic reviews. Journal of Mental Health Policy and Economics 1999; 2(3): 99-106.
9. Shemilt I, Mugford M, Byford S, et al. Incorporating economics evidence. In: Higgins JPT, Green S (eds) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 (updated September 2008). Oxford: Cochrane Collaboration, 2008.
10. Shemilt I, Mugford M, Byford S, et al. Campbell Collaboration Methods Policy Brief: economics methods. Oslo: Campbell Collaboration, 2008.
11. Cohen MA. Measuring the costs and benefits of crime and justice. In: Measurement and Analysis of Crime and Justice (Criminal Justice 2000, Volume 4). Washington DC: National Institute of Justice, 2000.
12. Byford S, McDaid D, Sefton TAJ. Because It's Worth It. A practical guide to conducting economic evaluations in the social welfare field. York: Joseph Rowntree Foundation, 2003.
13. Marsh K, Chalfin A, Roman J. What does economic analysis add to decision making? Evidence from the criminal justice literature. Journal of Experimental Criminology 2008; 4(2): 117-135.
14. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes, 3rd edn. Oxford: Oxford University Press, 2005.
15. National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. London: National Institute for Health and Clinical Excellence, 2008.
16. HM Treasury. The Green Book: appraisal and evaluation in central government. London: The Stationery Office, 2003.
17. Drummond MF, Manca A, Sculpher MJ. Increasing the generalisability of economic evaluations: recommendations for the design, analysis and reporting of studies. International Journal of Technology Assessment in Health Care 2005; 21: 165-171.
18. United Nations, European Commission, International Monetary Fund, Organisation for Economic Cooperation and Development, World Bank, Handbook of National Accounting: integrated environmental and economic accounting 2003 (Studies in Methods, Series F, No.61, Rev.1, Glossary). New York: United Nations, 2005.
19. Marsh K, Fox C. The benefit and cost of prison in the UK. The results of a model of lifetime re-offending. Journal of Experimental Criminology 2008; 4(4): 403-423.
20. Welsh B, Farrington DP. Monetary costs and benefits of crime prevention programs. In: Tonry M (ed) Crime and Justice: a review of research (Volume 27). Chicago: University of Chicago Press, 2000.
21. Drummond M, Iglesias C, Cooper NJ. Systematic reviews and economic evaluations in technology appraisals conducted for NICE in the UK: a game of two halves? International Journal of Technology Assessment in Health Care 2008; 24(2): 146-150.
22. Mugford M. Using systematic reviews for economic evaluation. In: Egger M, Davey Smith G, Altman D (eds) Systematic Reviews in Health Care: meta-analysis in context. London: BMJ Publishing Group, 2001.
23. Cooper NJ, Sutton AJ, Ades AE, Paisley S, Jones DR. Use of evidence in economic decision models: practical and methodological issues. Health Economics 2007; 16(12): 1277-1286.
24. Philips Z, Ginnelly L, Sculpher M, et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technology Assessment 2004; 8(36): 1-172.
25. Cooper NJ, Coyle D, Abrams KR, Mugford M, Sutton AJ. Use of evidence in decision models: an appraisal of health technology assessments in the UK to date. Journal of Health Services Research and Policy 2005; 10(4): 245-250.
26. Hanratty B, Craig D, Nixon J, Rice S, Christie J, Drummond MF. Are the best available clinical effectiveness data used in economic evaluations of drug therapies? Journal of Health Services Research and Policy 2007; 12(3): 138-141.
27. Deeks JJ, Higgins JPT, Altman DG (eds). Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (eds) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 (updated September 2008). Oxford: Cochrane Collaboration, 2008.
28. Demicheli V, Jefferson T, Vale L. Effectiveness estimates in economic evaluation. In: Donaldson C, Mugford M, Vale L (eds) Evidence-Based Health Economics: from effectiveness to efficiency in systematic review. London: BMJ Books, 2002.
29. Sculpher M, Fenwick E, Claxton K. Assessing quality in decision analytic cost-effectiveness models: a suggested framework and example of application. Pharmacoeconomics 2000; 17(5): 461-477.
30. Akehurst R, Anderson P, Brazier J, et al. Decision analytic modelling in the economic evaluation of health technologies-a consensus statement. Pharmacoeconomics 2000; 17(5): 443-444.
31. McCabe C, Dixon S. Testing the validity of cost-effectiveness models. Pharmacoeconomics 2000; 17(5): 501-513.
32. Halpern MT, McKenna M, Hutton J. Modeling in economic evaluation: an unavoidable fact of life. Health Economics 1998; 7(8): 741-742.
33. Hay JW. Economic modeling and sensitivity analysis. Value in Health 1998; 1(3): 187-193.
34. Weinstein MC, O'Brien BJ, Hornberger J, et al. Principles of good practice for decision analytic modeling in healthcare evaluation: report of the ISPOR Task Force on Good Research Practices-Modeling Studies. Value in Health 2003; 6(1): 9-17.
35. Habbema JD, Bossuyt PM, Dippel DW, Marshall S, Hilden J. Analysing clinical decision analyses. Statistics in Medicine 1990; 9(11): 1229-1242.
36. Nuijten MJC, Pronk MH, Brorens MJA, et al. Reporting format for economic evaluation: Part II: Focus on modelling studies. Pharmacoeconomics 1998; 14(3): 259-268.
37. Sendi PP, Craig BA, Pfluger D, Gafni A, Bucher HC. Systematic validation of disease models for pharmacoeconomic evaluations. Swiss HIV Cohort Study. Journal of Evaluation in Clinical Practice 1999; 5(3): 283-295.
38. Ramsey SD, Sullivan SD. Weighing the economic evidence: guidelines for critical assessment of cost-effectiveness analyses. Journal of the American Board of Family Practice 1999; 12(6): 477-485.
39. Eddy D. Technology assessment: the role of mathematical modelling. In Mosteller F (ed) Assessing Medical Technologies. Washington DC: National Academy Press, 1985.
40. Weinstein MC, Toy EL, Sandberg EA, et al. Modeling for health care and other policy decisions: uses, roles, and validity. Value in Health 2001; 4(5): 348-361.
41. Sonnenberg FA, Roberts MS, Tsevat J, Wong JB, Barry M, Kent DL. Toward a peer review process for medical decision analysis models. Medical Care 1994; 32(7 suppl): JS52-JS64.
42. Personal Social Services Research Unit. Unit Costs of Health and Social Care 2009. Canterbury: University of Kent, 2009.
43. Pharmaceutical Benefits Advisory Committee. Manual of Resource Items and Their Associated Costs for Use in Submissions to the Pharmaceutical Benefits Advisory Committee involving Economic Evaluation (second revision). Canberra: Australian Government Department of Health and Ageing, 2002. Available from: www.health.gov.au/internet/main/publishing.nsf/Content/health-pbs-general-pubs-manual-content.htm.
44. Castelli A. Guest editorial: National Schedule of Reference Costs data: Community Care Services. In: Personal Social Services Research Unit (ed) Unit Costs of Health and Social Care 2008. Canterbury: University of Kent, 2008.
45. British National Formulary. The British National Formulary, 57th edn. London: Pharmaceutical Press, 2009.
46. Institut für das Entgeltsystem im Krankenhaus (InEK). Website des Deutschen DRG-Systems. Siegburg: InEK, 2010. Available from: www.g-drg.de/cms/index.php.
47. Netten A, Barrett B Brookes N. Unit Costs in Criminal Justice (PSSRU Bulletin No. 18). Canterbury: University of Kent, 2008. Available from: www.pssru.ac.uk/pdf/b18/b18_ uccj.pdf.
48. Centre for Child and Family Research. Loughborough: Loughborough University, 2010. Available from: www.lboro.ac.uk/research/ccfr.
49. Centre for Reviews and Dissemination. NHS Economic Evaluation Database. York: Centre for Reviews and Dissemination, 2010. Available from: www.crd.york.ac.uk/crdweb.
50. Wiley Interscience. HEED: Health Economics Evaluation Database. Chichester: Wiley Interscience, 2010. Available from: http://heed.wiley.com.
51. American Economic Association. Econlit. Nashville: American Economic Association, 2010. Available from: www.aeaweb.org/econlit/index.php.
52. Hartley RJ, Keen EM, Large JA, Tedd LA. Online Searching: principles and practice. London: Bowker-Saur, 1990.
53. Bates MJ. The design of browsing and berrypicking techniques for the online search interface. Online Review 1989; 13(5): 407-424.
54. Sculpher M, Claxton K. Establishing the cost-effectiveness of new pharmaceuticals under conditions of uncertainty-when is there sufficient evidence? Value in Health 2005; 8(4): 433-446.
55. Coyle D, Lee KM. Evidence-based economic evaluation: how the use of different data sources can impact results. In: Donaldson C, Mugford M, Vale L (eds) Evidence-Based Health Economics: from effectiveness to efficiency in systematic review. London: BMJ Books, 2002.
56. Manca A, Willan AR. Lost in translation: accounting for between-country differences in the analysis of multinational cost-effectiveness data. Pharmacoeconomics 2006; 24(11): 1101-1119.
57. Sculpher MJ, Pang FS, Manca A, et al. Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technology Assessment 2004; 8(49): 1-192.
58. Longworth L. Guidelines for the reporting of evidence identification and selection in decision models: the NICE perspective. Presentation at MRC HSRC funded workshops on The Use of Evidence in Economic Decision Models-Workshop 2: Methodology for appropriate use of evidence in decision models. Leicester: University of Leicester, 2005. Available from: www2.le.ac.uk/Members/njc21/mrc-hsrcworkshop.
59. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 1996; 17(1): 1-12.
60. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. Ottawa: Ottawa Health Research Institute, 2010. Available from: www.ohri.ca/programs/clinicalepidemiology/oxford.htm.
61. Higgins JPT, Altman DG (eds). Assessing risk of bias in included studies. In: Higgins JPT, Green S (eds) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 (updated September 2008). Oxford: Cochrane Collaboration, 2008.
62. Cochrane Effective Practice and Organisation of Care Group. The EPOC Risk of Bias Guideline. Oxford: Cochrane Collaboration, 2009. Available from: www.epoc.cochrane.org/en/handsearchers.html.
63. Jefferson T, Vale L, Demicheli V. Methodological quality of economic evaluations of health care interventions-evidence from systematic reviews. In: Donaldson C, Mugford M, Vale L (eds) Evidence-Based Health Economics: from effectiveness to efficiency in systematic review. London: BMJ Books, 2002.
64. Drummond MF, Jefferson TO, on behalf of the BMJ Economic Evaluation Working Party. Guidelines for authors and peer reviewers of economic submissions to the BMJ. British Medical Journal 1996; 313(7052): 275-283.
65. Chiou C, Hay JW, Wallace JF, et al. Development and validation of a grading system for the quality of cost-effectiveness studies. Medical Care 2003; 41(1): 32-44.
66. Ofman JJ, Sullivan SD, Neumann PJ, et al. Examining the value and quality of health economic analyses: implications of utilizing the QHES. Journal of Managed Care Pharmacy 2003; 9(1): 53-61.
67. Evers S, Goossens M, de Vet H, van Tulder M, Ament A. Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. International Journal of Technology Assessment in Health Care 2005; 21(2): 240-245.
68. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. Journal of Epidemiology and Community Health 1998; 52(6): 377-384.
69. Sefton TAJ, Byford S, McDaid D, Hills J, Knapp M. Making the Most of It. Economic evaluation in the social welfare field. York: Joseph Rowntree Foundation, 2002.
70. Marsh K. Economic evaluation of criminal justice interventions: a methodological review of the recent literature. In: Dunworth T, Marsh K, Roman J, Mallender J (eds) Cost-Benefit Analysis of Criminal Justice Interventions. Washington DC: Urban Institute Press, in press.
71. Drummond M, Weatherly H, Claxton K, et al. Assessing the Challenges of Applying Standard Methods of Economic Evaluation to Public Health Interventions. York: Public Health Research Consortium, 2007.
72. Kelly M, McDaid D, Ludbrook A, Powell J. Economic Appraisal of Public Health Interventions. London: Health Development Agency, 2005.
73. Farrington DP, Welsh BC. Randomised experiments in criminology: what have we learned in the last two decades? Journal of Experimental Criminology 2005; 1(1): 9-38.
74. Shemilt I, Pössel P, Mugford M, Valentine JC. Costing program implementation using systematic review: programs to prevent adolescent depression. Oral paper presentation at the Ninth Annual Colloquium of the Campbell Collaboration, Oslo, 18-20 May, 2009.
75. Claxton K, Sculpher M, Culyer A. Mark versus Luke? Appropriate methods for the evaluation of public health interventions (CHE Research Paper 31). York: Centre for Health Economics, University of York, 2007.
76. Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgements. British Medical Journal 2004; 329(7459), 224-227.
77. Brand S, Price R. The Economic and Social Costs of Crime (Home Office Research Study 217). London: Home Office, 2000.
78. Dubourg R, Hamed J, Thorns J. The Economic and Social Costs of Crime Against Individuals and Households 2003/04 (Home Office Online Report 30/05). London: Home Office. Available from: www.homeoffice.gov.uk/rds/pdfs05/ rdsolr3005.pdf.
79. McCormack K, Wake B, Perez J, et al. Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation. Health Technology Assessment 2006; 9(14): 1-203.
80. Dolan P, Metcalfe R, Munro V, Christensen MC. Valuing lives and life years: anomalies, implications and an alternative. Health Economics, Policy, and Law 2008; 3(3): 277-300.
81. Dolan P, Peasgood T, White M. Do we really know what makes us happy? A review of the economic literature on the factors associated with subjective well-being. Journal of Economic Psychology 2008; 29(1): 93-122.
82. Organisation for Economic Cooperation and Development. Is happiness measurable and what do those measures mean for policy? International conference, Rome, 2-3 April 2007. Available from: www.oecd.org/oecdworldforum/happiness.